Shuo Yu

701 total citations
14 papers, 401 citations indexed

About

Shuo Yu is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Shuo Yu has authored 14 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Physiology. Recurrent topics in Shuo Yu's work include Sirtuins and Resveratrol in Medicine (2 papers), Diet and metabolism studies (2 papers) and Acupuncture Treatment Research Studies (2 papers). Shuo Yu is often cited by papers focused on Sirtuins and Resveratrol in Medicine (2 papers), Diet and metabolism studies (2 papers) and Acupuncture Treatment Research Studies (2 papers). Shuo Yu collaborates with scholars based in China and United States. Shuo Yu's co-authors include Qinhong Xu, Wanxing Duan, Qingyong Ma, Jiguang Ma, Liansheng Gong, Yifeng Pan, Nianfeng Li, Lun Zhang, Erxi Wu and Wei Li and has published in prestigious journals such as PLoS ONE, ACS Applied Materials & Interfaces and Organic Letters.

In The Last Decade

Shuo Yu

14 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuo Yu China 9 197 97 84 42 38 14 401
Usama Khamis Hussein Egypt 13 281 1.4× 111 1.1× 79 0.9× 37 0.9× 45 1.2× 26 544
Xunxia Bao China 10 177 0.9× 101 1.0× 60 0.7× 20 0.5× 24 0.6× 19 392
Joohyun Ryu United States 15 298 1.5× 80 0.8× 77 0.9× 36 0.9× 20 0.5× 27 475
Anna Klimaszewska‐Wiśniewska Poland 13 297 1.5× 77 0.8× 75 0.9× 60 1.4× 13 0.3× 41 522
V. Vijaya Padma India 14 233 1.2× 49 0.5× 77 0.9× 28 0.7× 23 0.6× 21 478
Yao Wu China 8 198 1.0× 57 0.6× 51 0.6× 39 0.9× 88 2.3× 12 393
Hye Kyeong Yun South Korea 14 264 1.3× 95 1.0× 97 1.2× 39 0.9× 12 0.3× 18 570
Xiuhua Xu China 15 222 1.1× 66 0.7× 84 1.0× 11 0.3× 37 1.0× 24 483
Daming Ou China 5 315 1.6× 53 0.5× 135 1.6× 29 0.7× 24 0.6× 7 527

Countries citing papers authored by Shuo Yu

Since Specialization
Citations

This map shows the geographic impact of Shuo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Yu more than expected).

Fields of papers citing papers by Shuo Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Yu. The network helps show where Shuo Yu may publish in the future.

Co-authorship network of co-authors of Shuo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Yu. A scholar is included among the top collaborators of Shuo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Yu. Shuo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Yu, Shuo, Huan Shen, Xi Chen, et al.. (2024). A cascade nanosystem with “Triple-Linkage” effect for enhanced photothermal and activatable metal ion therapy for hepatocellular carcinoma. Journal of Nanobiotechnology. 22(1). 334–334. 5 indexed citations
4.
Li, Dong, et al.. (2024). Photoredox/HAT-Catalyzed Intramolecular Hydrocyclization of Alkenes toward 2,3-Fused Quinazolinones and Dihydroquinazolinones. Organic Letters. 26(41). 8756–8761. 5 indexed citations
5.
Zhang, Lu, Ying Guo, Shuo Yu, et al.. (2023). A Glucose Metabolic Intervention Nanoplatform for Enhanced Chemodynamic Therapy and Sensitized Photothermal Therapy of Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 15(21). 25437–25451. 22 indexed citations
6.
Li, Dong, Xiaoqing Wang, Shuo Yu, et al.. (2022). Regioselective Perfluoroalkylation of 4‐Quinolones Using Sodium Perfluoroalkyl Sulfinates. European Journal of Organic Chemistry. 2022(37). 3 indexed citations
8.
Huang, Ke, et al.. (2021). Acupuncture treatment of diabetic peripheral neuropathy: An overview of systematic reviews. Journal of Clinical Pharmacy and Therapeutics. 46(3). 585–598. 21 indexed citations
10.
Yu, Shuo, Liansheng Gong, Nianfeng Li, Yifeng Pan, & Lun Zhang. (2017). Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways. Biomedicine & Pharmacotherapy. 97. 213–224. 80 indexed citations
11.
Han, Liang, Jiguang Ma, Wanxing Duan, et al.. (2016). Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway. Oncotarget. 7(14). 18146–18158. 41 indexed citations
12.
Zhang, Lun, Jiahui Li, Jiguang Ma, et al.. (2015). The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. Oxidative Medicine and Cellular Longevity. 2016(1). 3897250–3897250. 28 indexed citations
13.
Shen, Xin, Zhenhua Ma, Chao Chen, et al.. (2013). Aspirin: A Potential Therapeutic Approach in Pancreatic Cancer. Current Medicinal Chemistry. 20(33). 4153–4162. 10 indexed citations
14.
Li, Wei, Jiguang Ma, Qingyong Ma, et al.. (2013). Resveratrol Inhibits the Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells Via Suppression of the PI-3K/Akt/NF-κB Pathway. Current Medicinal Chemistry. 20(33). 4185–4194. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026